萘丁美酮在混合反流模型干预治疗中的作用

目的探讨萘丁美酮在混合反流模型干预治疗中的作用。方法健康SD大鼠100只,随机分为反流模型组(Y组,46只)、萘丁美酮组(R组,46只)和正常对照组(C组,8只)。分别观察Y组、R组术后5、17、28、40周及C组40周时食管黏膜的病理改变,检测环氧合酶-2(COX-2)、增殖细胞核抗原(PCNA)、细胞周期蛋白D1(CD1)的表达情况。结果①R组不同时段的损伤积分和Barrett食管(BE)的发生率均低于Y组。②Y组COX-2、PCNA及CD1从正常→反流性食管炎(RE)→BE→食管腺癌(EAC)的阳性表达率和表达程度逐渐增强。③R组不同时段COX-2、PCNA、CD1的表达均低于Y组,且COX-2表达程度和阳性表达率与Y组相比均有统计学意义(P<0.05);R组40周PCNA的表达程度及阳性表达率与Y组相比有统计学差异(P<0.05)。结论COX-2、PCNA和CD1基因的高表达参与了从RE→BE→EAC的发展过程,是BE、EAC发生、发展的早期分子事件。萘丁美酮可影响COX-2、PCNA和CD1的表达,减轻炎症的程度并减缓病程的进展,降低BE和重度不典型增生的发生率,抑制腺癌的发生。

The preventive effect of nabumetone in the model of reflux esophagitis

Objective To investigate the preventive effect of nabumetone on the damaged esophageal mucosa in the model of reflux esophagitis, and the effect of expression of cyclooxygenase-2(COX-2), proliferating cell nuclear antigen(PCNA), cyclin D_ 1 (CD_ 1 ) on the progress of reflux esophagitis. Methods A total of 100 SD rats were divided into three groups in random: group Y: operation + saline as positive controls(46); group R: operation + nabumetone(46); and group C: normal control(8). The lesions of esophageal mucosa were observed in the 5th, 17th, 28th , 40th week in groups Y and R and 40th week in group C, respectively. The change of COX-2, PCNA, and CD_ 1 by immunoperoxidase staining in the progress of reflux esophagitis(RE) and the effect of nabumetone were evaluated. Results The lesions of esophageal mucosa at different time and the incidence of Barrett's esophagus(BE) in group R were lower than those in group Y (P<0.05). ② The expressions of COX-2, PCNA and CD_1 increased gradually from normal→RE→BE→esophageal adenocacinoma (EAC) in group Y. ③ The expressions of COX-2, PCNA and CD_ 1 in group R were lower than those in group Y at different time, and the expression of COX-2 significantly differed between group Y and R(P<0.05). Conclusion In the progress of RE, COX-2, PCNA, and CD_ 1 increase gradually. Nabumetone reduces mucosa injury in RE and inhibits the development of BE by affecting the expression of COX-2, PCNA, and CD_1.